# Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel

> **NCT00697437** · PHASE2 · COMPLETED · sponsor: **National University Hospital, Singapore** · enrollment: 10 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Ketoconazole

## Key facts

- **NCT ID:** NCT00697437
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00697437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00697437, "Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00697437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*